Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy

Transplantation

Volumn 96, Issue 2, 2013, Pages 139-145

  Goto, Ryoichi ^a   Issa, Fadi ^a   Heidt, Sebastiaan ^a   Taggart, David ^b   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HLA ANTIBODY; SODIUM CHLORIDE; DNA BINDING PROTEIN; HETEROPHILE ANTIBODY; HLA ANTIGEN CLASS 1; RAG2 PROTEIN, MOUSE; ALLOANTIBODY; HLA ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD VESSEL TRANSPLANTATION; COLD ISCHEMIA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEART SURGERY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; ORGAN DONOR; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSPLANT VASCULOPATHY; ABDOMINAL AORTA; ANIMAL; BAGG ALBINO MOUSE; BLOOD VESSEL GRAFT; CROSS REACTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MAMMARY ARTERY; METHODOLOGY; PATHOLOGY; POSTOPERATIVE COMPLICATION; TRANSPLANTATION; XENOGRAFT; BLOOD VESSEL; DONOR; GRAFT REJECTION; INJURY; INTIMA; METABOLISM;

ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODY SPECIFICITY; AORTA, ABDOMINAL; COLD ISCHEMIA; CROSS REACTIONS; DNA-BINDING PROTEINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MAMMARY ARTERIES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; POSTOPERATIVE COMPLICATIONS; RECEPTORS, FC; REPERFUSION INJURY; TRANSPLANTATION, HETEROLOGOUS; VASCULAR GRAFTING; BLOOD VESSELS; GRAFT REJECTION; HLA ANTIGENS; ISOANTIBODIES; RECEPTORS, IGG; TISSUE DONORS; TUNICA INTIMA;

EID: 84880538750     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318295ee32     Document Type: Article

References (44)

1. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387.
2. Nadig SN, Wieckiewicz J, Wu DC, et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010; 16: 809.
3. Uehara S, Chase CM, Kitchens WH, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 3424.
4. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007; 100: 967.
5. Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012; 93: 1.
6. Hidalgo LG, Campbell PM, Sis B, et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
7. Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357: 1293.
8. Jurcevic S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886.
9. Win TS, Pettigrew GJ. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 2010; 90: 113.
10. Hill GS, Nochy D, Bruneval P, et al. Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol 2011; 22: 975.
11. Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008; 86: 377.
12. Hirohashi T, Uehara S, Chase CM, et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010; 10: 510.
13. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994; 152: 5135.
14. Alkhatib B, Freguin-Bouilland C, Litzler PY, et al. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats. J Thorac Cardiovasc Surg 2007; 133: 791.
15. Jindra PT, Hsueh A, Hong L, et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008; 180: 2214.
16. Galvani S, Auge N, Calise D, et al. HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant 2009; 9: 2607.
17. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983; 49: 327.
18. Isik FF,McDonald TO, Ferguson M, et al. Transplant arteriosclerosis in a rat aortic model. Am J Pathol 1992; 141: 1139.
19. Kouwenhoven EA, Marquet RL, Bonthuis F, et al. The role of alloantigen-independent factors in transplant arteriosclerosis. Transplant Proc 1997; 29: 1721.
20. Issa F, Hester J, Goto R, et al. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 2010; 90: 1321.
21. Koulack J, McAlister VC, Giacomantonio CA, et al. Development of a mouse aortic transplant model of chronic rejection. Microsurgery 1995; 16: 110.
22. Pober JS, Bothwell AL, Lorber MI, et al. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin Immunopathol 2003; 25: 167.
23. Gaudin PB, Rayburn BK,HutchinsGM, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994; 18: 338.
24. Neil DA, Lynch SV, Hardie IR, et al. Cold storage preservation and warm ischaemic injury to isolated arterial segments: endothelial cell injury. Am J Transplant 2002; 2: 400.
25. Schuurman HJ, Pally C, Weckbecker G, et al. SDZ RAD inhibits cold ischemia-induced vascular remodeling. Transplant Proc 1999; 31: 1024.
26. Myllarniemi M, Raisanen-Sokolowski A, Vuoristo P, et al. Lack of effect of recombinant human superoxide dismutase on cold ischemiainduced arteriosclerosis in syngeneic rat aortic transplants. Transplantation 1996; 61: 1018.
27. Dragun D, Hoff U, Park JK, et al. Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int 2001; 60: 1173.
28. Herrero-Fresneda I, Torras J, Lloberas N, et al. Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. Transplantation 2000; 70: 1624.
29. Hirohashi T, Chase CM, Della Pelle P, et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 2012; 12: 313.
30. Morrell CN, Murata K, Swaim AM, et al. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res 2008; 102: 777.
31. Furukawa Y, Libby P, Stinn JL, et al. Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in nonimmunosuppressed hosts. Am J Pathol 2002; 160: 1077.
32. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 1994; 91: 812.
33. KitchensWH,ChaseCM,Uehara S, et al.Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007; 7: 2675.
34. Chung JH, Jeon HJ, Hong SY, et al. Palmitate promotes the paracrine effects of macrophages on vascular smooth muscle cells: the role of bone morphogenetic proteins. PLoS One 2012; 7: e29100.
35. Ross R. AtherosclerosisVan inflammatory disease. N Engl J Med 1999; 340: 115.
36. Mitchell RN. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol 2009; 4: 19.
37. Lefaucheur C, Nochy D, Hill GS, et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7: 832.
38. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63: 1888.
39. Fahim T, Bohmig GA, Exner M, et al. The cellular lesion of humoral rejection: predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7: 385.
40. Mizutani K, Terasaki P, Rosen A, et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005; 5: 2265.
41. Win TS, Rehakova S, Negus MC, et al. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Circ Heart Fail 2009; 2: 361.
42. Roder J, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature 1979; 278: 451.
43. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010; 10: 1812.
44. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A 2007; 104: 1301.